Pharm'Up
Merck has revealed that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review...
Novartis has disclosed the preliminary findings from its Phase III GCAptAIN study, assessing Cosentyx® (secukinumab) for the...
Global pharmaceutical leader Lupin Limited has unveiled the launch of Ipratropium Bromide Nasal Solution (Nasal Spray) in...
Biocon Biologics Ltd. (BBL), a leading global biosimilars company and subsidiary of Biocon Ltd., has received marketing...
Pharm'Up
HUMAN ANATOMY AND PHYSIOLOGY-I THEORY (BP101T) HUMAN-ANATOMY-AND-PHYSIOLOGY-I (BP101T) MAY-2025 BP101T Human Anatomy and Physiology I– Theory BP102T...
A comprehensive study by NYU Langone Health revealed a significant link between daily exposure to di-2-ethylhexyl phthalate...
Novartis achieved a major milestone in global child health with the Swissmedic approval of Coartem® Baby (artemether-lumefantrine),...
Lupin Limited, a global pharmaceutical leader, and Zentiva Group, a prominent pan-European pharmaceutical company, announced a landmark...
Milestone Pharmaceuticals Inc. has announced that the U.S. Food and Drug Administration (FDA) has officially accepted its...
Ascentage Pharma, a global biopharmaceutical company focused on addressing unmet medical needs in cancers, has announced that...
